Results 201 to 210 of about 93,643 (333)
Neurodevelopmental Vulnerability in Alzheimer's Disease and Frontotemporal Dementia. [PDF]
Siguier PLM+18 more
europepmc +1 more source
Abstract Mild cognitive impairment (MCI) is a high‐risk state for dementia, marked by cognitive decline with preserved daily functioning. Combined physical and cognitive activity (PA+CA) programs show promising benefits for MCI patients. Involving adult children through intergenerational approaches may enhance participation and impact, yet little is ...
Julie Latomme+3 more
wiley +1 more source
Fluid biomarkers in familial frontotemporal dementia: progress and prospects. [PDF]
Guo M+8 more
europepmc +1 more source
An evidence-based algorithm for the utility of FDG-PET for diagnosing Alzheimer's disease according to presence of medial temporal lobe atrophy [PDF]
Cam Donaldson+13 more
core +1 more source
Abstract INTRODUCTION Plasma biomarkers offer promise for improving the diagnosis of Alzheimer's disease (AD) and differentiating AD and other neurodegenerative disorders (NDs) like frontotemporal dementia (FTD) from primary psychiatric disorders (PPDs), particularly in younger patients.
Dhamidhu Eratne+14 more
wiley +1 more source
Frontotemporal dementia deficit in Theory of Mind assessed with Happé’s Test
Daniel Serrani
openalex +2 more sources
Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations [PDF]
Alejandra del C. Alonso+4 more
openalex +1 more source
Machine-Learning Applications in Frontotemporal Dementia: Challenges, Prospects and Viable Clinical Applications. [PDF]
Bede P, Siah WF, Kassubek J.
europepmc +1 more source
Abstract INTRODUCTION Type 2 diabetes mellitus (T2DM) is a risk factor for dementia and cerebral small vessel disease, but there remains a need to identify targetable molecular pathways involved in the underlying pathophysiology. METHODS In participants with Alzheimer's disease, related dementias, or cerebrovascular diseases, we assessed associations ...
Si Won Ryoo+22 more
wiley +1 more source